The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Dec. 01, 2011
Applicants:

Cam Patterson, Chapel Hill, NC (US);

Anka N. Veleva, Cary, NC (US);

Inventors:

Cam Patterson, Chapel Hill, NC (US);

Anka N. Veleva, Cary, NC (US);

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 38/04 (2006.01); A61K 47/48 (2006.01); C07K 7/08 (2006.01); A61K 51/08 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48246 (2013.01); A61K 38/04 (2013.01); A61K 51/088 (2013.01); C07K 7/08 (2013.01); A61B 5/0071 (2013.01); A61B 5/0075 (2013.01); G01N 33/57484 (2013.01); G01N 2500/00 (2013.01); G01N 2500/10 (2013.01); G01N 2800/7014 (2013.01);
Abstract

Compositions and methods for targeted delivery to and detection of sites of neovascular growth, including tumor vasculature, are provided. Compositions include polypeptides conjugated to or complexed with a bioactive compound, wherein the polypeptide is capable of binding to an OEC or a circulating progenitor thereof. Methods for identifying additional polypeptides with the same binding characteristics are further provided. Methods for targeted delivery of a bioactive compound to a site of neovascular growth are provided in which polypeptides capable of binding OECs or progenitors thereof are conjugated to or complexed with the bioactive compound and administered to a subject in need thereof. Methods for detecting neovascular growth are also provided, wherein the polypeptides conjugated to or complexed with a detectable label are administered to a subject and the label is detected.


Find Patent Forward Citations

Loading…